Abstract:Prion diseases and prion-like protein misfolding diseases involve the accumulation of abnormally aggregated forms of the normal host proteins, such as prion protein and Tau protein. These proteins are special because of their self-duplicating and transmissible characteristics. Such abnormally aggregated proteins mainly formed in neurons, cause the neurons dysfunction, and finally lead to invariably fatal neurodegenerative diseases. Prion diseases appear not only in animals, such as bovine spongiform encephalopathy in cattle and scrapie in sheep, but also in humans, such as Creutzfeldt-Jacob disease, and even the same prion or prion-like proteins can have many different phenotypes. A lot of biological evidence has suggested that the molecular basis for different strains of prions could be hidden in protein conformations, and the misfolded proteins with conformations different from the normal proteins have been proved to be the main cause for protein aggregation. Crowded physiological environments can be imitated in vitro to study how the misfolding of these proteins leads to the diseases in vivo. In this review, we provide an overview of the existing structural information for prion and prion-like proteins, and discuss the post-translational modifications of prion proteins and the difference between prion and other infectious pathogens. We also discuss what makes a misfolded protein become an infectious agent, and show some examples of prion-like protein aggregation, such as Tau protein aggregation and superoxide dismutase 1 aggregation, as well as some cases of prion-like protein aggregation in crowded physiological environments.

The Progress in Amyloid Deposition Diseases at Cellular Level

Progress in molecular mechanisms of β-amyloid peptides in alzheimer's disease

Molecular Simulations of Amyloid Structures, Toxicity, and Inhibition

Amyloid-Induced Neurodegeneration: A Comprehensive Review through Aggregomics Perception of Proteins in Health and Pathology

Pathways of amyloid fibril formation and protein aggregation

Interaction Between Amyloidogenic Proteins and Biomembranes in Protein Misfolding Diseases: Mechanisms, Contributors, and Therapy

Protein aggregation and its affecting mechanisms in neurodegenerative diseases

Recent progress in prion and prion-like protein aggregation.

Pathological Involvement of Protein Phase Separation and Aggregation in Neurodegenerative Diseases

Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.

How our bodies fight amyloidosis: effects of physiological factors on pathogenic aggregation of amyloidogenic proteins

Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer’s Disease, Parkinson’s Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis

Advances in functions of cellular prion protein in Alzheimer’s disease

Protein Folding and Formation of Amyloid Deposition

Aggregation mechanisms and molecular structures of amyloid‐β in Alzheimer's disease

Cell-to-cell Transmission of Pathogenic Proteins in Neurodegenerative Diseases

Protein misfolding and aggregation in neurodegenerative diseases: a review of pathogeneses, novel detection strategies, and potential therapeutics

Decoding the Cellular Trafficking of Prion-like Proteins in Neurodegenerative Diseases

Probing the Interactions Between Amyloidogenic Proteins and Bio-Membranes.

Misfolded Protein Aggregation and Altered Cellular Pathways in Neurodegenerative Diseases

Misfolded protein oligomers: mechanisms of formation, cytotoxic effects, and pharmacological approaches against protein misfolding diseases